Federal University of Health Science of Porto Alegre
Also known as: Alessandro Pasqualotto | Cardiology Post Graduated Program, Federal University of Rio Grande do Sul, Hospital de Clinicas de Porto Alegre | Centro Municipal de DST/AIDS, Irmandade Santa Casa de Misericordia de Porto Alegre | Complexo Hospitalar Santa Casa de Misericordia de Porto alegre | Federal Health Science University of Porto Alegre | Federal University of Health Science of Porto Alegre | Federal University of Health Sciences of Porto Alegre | Federal University of Healthy Sciences of Porto Alegre (UFCSPA) | Fundação Médica do Rio Grande do Sul | HCPA | HCPorto Alegre | Hospital das Clínicas de Porto Alegre | Hospital de Clinicas de Porto Alegre | Hospital de clínicas de porto alegre | Hospital de Clínicas de Porto Alegre | Hospital de Clinicas de Porto Algre | Hospital Espirita de Porto Alegre | Hospital of Clinics of Porto Alegre | Irmandade Santa Casa de Misericórdia de Porto Alegre | Kidney & Pancreas Transplant Unit, Santa Casa de Misericordia, Porto Alegre, Brazil | Mariane Bagatin Bermudez | Professor of the Post Graduate Program in Endocrinology at the Hospital de Clinicas de Porto Alegre | Santa Casa de Misericórdia de Porto Alegre | UFRGS and Hospital de Clínicas de Porto Alegre (HCPA)
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2003Last known activity
Feb 1, 2026
Timeline
1950s
- Jun 1, 1953
Federal University of Health Science of Porto Alegre— Founded
Drugs by trial phase (80 distinct, 69 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (27 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Acute Pain
- Atherosclerosis
- Bipolar Disorder
- Brain Death
- Bronchopulmonary Dysplasia
- Cardiovascular Diseases
- Cheilitis
- Chronic Pain
- Common Cold
- Coronary Artery Disease
- Death
- Depression
- Depressive Disorder
- Disease
- Essential Hypertension
- Fibromyalgia
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- Histoplasmosis
- HIV Infections
- Homocystinuria
- Hyperandrogenism
- Hypertension
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lung Diseases, Obstructive
- Mood Disorders
- Mucopolysaccharidoses
- Mucopolysaccharidosis IV
- Mucopolysaccharidosis VI
- Myofascial Pain Syndromes
- Obesity
- Osteochondrodysplasias
- Polycystic Ovary Syndrome
- Premenstrual Syndrome
- Pulmonary Disease, Chronic Obstructive
- Schizophrenia
- Sleep Disorders, Circadian Rhythm
- Sleep Wake Disorders
- Syndrome
- Viremia
Recent trials (50)
- NCT07261150CollaboratorPhase 3Feb 1, 2026
- NCT07203339Lead sponsorN/ASep 30, 2025
- NCT07052058Lead sponsorPhase 2Aug 25, 2025
- NCT06783478Lead sponsorPhase 2Apr 1, 2025
- NCT06591884OfficialPhase 1/Phase 2Sep 3, 2024
- NCT06591884Lead sponsorPhase 1/Phase 2Sep 3, 2024
- NCT06622187Lead sponsorPhase 4Aug 14, 2024
- NCT06434025Sponsor investigatorPhase 3May 24, 2024
- NCT06434025Lead sponsorPhase 3May 24, 2024
- NCT06434025OfficialPhase 3May 24, 2024
- NCT06354439OfficialPhase 4Mar 27, 2024
- NCT06354439Lead sponsorPhase 4Mar 27, 2024
- NCT05814432Study chairPhase 3Sep 1, 2023
- NCT05814432Reponsible party - principal investigatorPhase 3Sep 1, 2023
- NCT05814432Sponsor investigatorPhase 3Sep 1, 2023
Details
- Founded
- Porto Alegre, BR Jun 1, 1953
- Last known activity
- Feb 1, 2026